Contraceptive Patch Maker Agile Recapitalizes With $45 Million Venture Round
This article was originally published in The Pink Sheet Daily
Executive Summary
Agile said in 2008 its lead product was ready for Phase III trials. Those trials might start soon, now that the firm has found new backers.